Trillium Therapeutics Inc (TRIL)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC:

96 SKYWAY AVENUE TORONTO, ONTARIO, CANADA M9W 4Y9

Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system.

Data as of 2021-04-17 10:16:22 -0400
Market Cap1.028 Billion Shares Outstanding103.021 Million Avg 30-day Volume949.178 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-13.12 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.45745 52-week High/Low20.96 / 4.05 Next Earnings Date2021-05-14 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from TRIL instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 7 6 16.67% 7 (0.42%) 6 (0.37%) 16.67%
Funds Holding: 131 112 16.96% 53 (3.19%) 47 (2.93%) 12.77%
13F shares: 76.071 Million 67.978 Million 11.91% 48.262 Million 48.141 Million 0.25%
% Ownership 85.7773 76.6514 11.91% 54.4204 54.2836 0.25%
New Positions: 39 41 -4.88% 17 16 6.25%
Increased Positions 56 37 51.35% 18 17 5.88%
Closed Positions 21 12 75.0% 12 3 300.0%
Reduced Positions 27 25 8.0% 16 11 45.45%
Total Calls 1.62 Million 678.972 Thousand 138.54% 597.713 Thousand 323.46 Thousand 84.79%
Total Puts 1.755 Million 488.819 Thousand 259.11% 435.979 Thousand 115.5 Thousand 277.47%
PUT/CALL Ratio 1.08 0.72 50.0% 0.73 0.36 102.78%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TRIL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TRIL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

20.8 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

20.8 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PETROVA PENKA CHIEF DEVELOPMENT OFFICER

  • Officer
133,440 2021-04-08 7

UGER ROBERT CHIEF SCIENTIFIC OFFICER

  • Officer
113,021 2021-04-07 8

SKVARKA JAN PRESIDENT AND CEO

  • Officer
  • Director
0 2021-01-13 2

PARSONS JAMES T. CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-08 2

BESHAR LUKE M

  • Director
0 2021-01-01 1

KIRKMAN ROBERT L

  • Director
0 2021-01-01 1

REYNOLDS THOMAS C

  • Director
0 2021-01-01 1

PUCCI PAOLO

  • Director
0 2021-01-01 1

KAMARCK MICHAEL E.

  • Director
0 2021-01-01 1

WALKER PAUL EDWARD

  • Director
5,736,363 2021-01-01 1

TAYTON-MARTIN HELEN KATRINA

  • Director
0 2021-01-01 1

BRUNS INGMAR CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-01 1

HARRISON ROSEMARY SEE REMARKS

  • Officer
75 2021-01-01 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-04-09 17:23:07 -0400 2021-04-08 M 2,708 d 83,960 direct yes

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-04-09 17:23:07 -0400 2021-04-08 M 2,708 $0.30 a 2,708 direct yes 2.1277 -2.4316 5.1672 4 -2.4316 6

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-04-09 17:23:07 -0400 2021-04-08 S 5,312 $11.09 d 0 direct yes 2.1277 -2.4316 5.1672 4 -2.4316 6

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-04-09 17:23:07 -0400 2021-04-08 M 2,604 d 49,480 direct yes

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-04-09 17:23:07 -0400 2021-04-08 M 2,604 $3.36 a 5,312 direct yes 2.1277 -2.4316 5.1672 4 -2.4316 6

UGER ROBERT - Officer CHIEF SCIENTIFIC OFFICER

2021-04-09 17:38:51 -0400 2021-04-07 S 3,646 $10.82 d 0 direct yes 2.1277 -2.4316 5.1672 4 -2.4316 6

UGER ROBERT - Officer CHIEF SCIENTIFIC OFFICER

2021-04-09 17:38:51 -0400 2021-04-07 M 3,646 $0.30 a 3,646 direct yes 2.1277 -2.4316 5.1672 4 -2.4316 6

UGER ROBERT - Officer CHIEF SCIENTIFIC OFFICER

2021-04-09 17:38:51 -0400 2021-04-07 M 3,646 d 113,021 direct yes

UGER ROBERT - Officer CHIEF SCIENTIFIC OFFICER

2021-03-15 17:12:38 -0400 2021-03-12 M 2,917 $3.39 a 2,917 direct yes 1.9462 -2.9657 2.595 5 -2.9657 3

UGER ROBERT - Officer CHIEF SCIENTIFIC OFFICER

2021-03-15 17:12:38 -0400 2021-03-12 M 2,917 d 58,333 direct yes

UGER ROBERT - Officer CHIEF SCIENTIFIC OFFICER

2021-03-15 17:12:38 -0400 2021-03-12 S 2,917 $11.97 d 0 direct yes 1.9462 -2.9657 2.595 5 -2.9657 3

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-03-12 16:40:54 -0500 2021-03-10 S 5,312 $11.08 d 0 direct yes -2.7051 -0.1803 0.0 1 -5.5906 4

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-03-12 16:40:54 -0500 2021-03-10 M 2,604 d 52,084 direct yes

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-03-12 16:40:54 -0500 2021-03-10 M 2,604 $3.35 a 5,312 direct yes -2.7051 -0.1803 0.0 1 -5.5906 4

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-03-12 16:40:54 -0500 2021-03-10 M 2,708 d 86,668 direct yes

PETROVA PENKA - Officer CHIEF DEVELOPMENT OFFICER

2021-03-12 16:40:54 -0500 2021-03-10 M 2,708 $0.30 a 2,708 direct yes -2.7051 -0.1803 0.0 1 -5.5906 4

UGER ROBERT - Officer CHIEF SCIENTIFIC OFFICER

2021-03-10 17:57:27 -0500 2021-03-08 M 3,646 $0.30 a 3,646 direct yes 2.5575 -10.7417 2.5575 2 -10.7417 6

UGER ROBERT - Officer CHIEF SCIENTIFIC OFFICER

2021-03-10 17:57:27 -0500 2021-03-08 M 3,646 d 116,667 direct yes

UGER ROBERT - Officer CHIEF SCIENTIFIC OFFICER

2021-03-10 17:57:27 -0500 2021-03-08 S 3,646 $10.11 d 0 direct yes 2.5575 -10.7417 2.5575 2 -10.7417 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 22:15:03 UTC -0.8903 0.9503 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 21:45:03 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 21:15:02 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 20:45:03 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 20:15:04 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 19:45:03 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 19:15:03 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 18:45:03 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 18:15:03 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 17:45:02 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 17:15:02 UTC -0.8854 0.9454 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 16:45:03 UTC -0.874 0.934 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 16:15:03 UTC -0.874 0.934 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 15:45:03 UTC -0.874 0.934 500000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 15:15:02 UTC -0.874 0.934 350000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 14:45:03 UTC -0.9547 1.0147 350000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 14:15:03 UTC -0.9547 1.0147 350000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 13:45:03 UTC -0.9547 1.0147 350000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 13:15:04 UTC -0.9547 1.0147 200000
TRILLIUM THERAPEUTICS INC TRIL 2021-04-20 12:45:03 UTC -0.9547 1.0147 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TRIL -26300.0 shares, $-386873.0 2020-12-31 N-PORT

Elevate your investments